Investing in These 2 Stocks Now Could Help You Retire Early

Motley Fool2021-08-27

Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（14）

Favian
·2021-08-29
okay
Reply
1
Report
andrew123
·2021-08-29
tKs 4 tips.liken comment
Reply
1
Report
Fold Replies
- Favian:
  okie
  2021-08-29
  Reply
  Report
- DannyPhan:
  thanks
  2021-08-29
  Reply
  Report
sophialoh
·2021-08-28
this is interesting
Reply
1
Report
Fold Replies
- 1Robo:
  ok
  2021-08-29
  Reply
  Report
Slowmopi
·2021-08-28
Ok
Reply
3
Report
Rickyt089
·2021-08-28
Like pls
Reply
3
Report
Fold Replies
- andrew123:
  done.like back
  2021-08-29
  Reply
  Report
Potatoclown
·2021-08-27
I want to retire now
Reply
7
Report
Fold Replies
- lsn_9812:
  ????
  2021-08-30
  Reply
  Report
- MOON88:
  Cool
  2021-08-28
  Reply
  Report
- Rickyt089:
  Nice
  2021-08-28
  Reply
  Report
View more 2 comments
gum
·2021-08-27
Any stocks that can help me to retire immediately?
Reply
4
Report
Glarethis
·2021-08-27
Hi
Reply
6
Report
Skygeemusic
·2021-08-27
How reliable is this prediction?
Reply
4
Report
Ladious
·2021-08-27
Like
Reply
6
Report
Fold Replies
- Yulio:
  Liked
  2021-08-27
  Reply
  Report
themonkey
·2021-08-27
[摳鼻] [摳鼻] [摳鼻]
Reply
3
Report
Fold Replies
- Xann:
  Ok
  2021-08-27
  Reply
  Report
CK88
·2021-08-27
Thanks
Reply
3
Report
Fold Replies
- terry89:
  ok
  2021-08-27
  Reply
  Report
- lowniu:
  Yeah
  2021-08-27
  Reply
  Report
Finree
·2021-08-27
High imagination stock [微笑]
Reply
Like
Report
Kelvinneo
·2021-08-27
Like
Reply
6
Report
Fold Replies
- CK88:
  ok
  2021-08-27
  Reply
  Report
- mingliang104:
  Nice
  2021-08-27
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2162724042?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-27 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2162724042","market":"us","top_or_hot":-1,"title":"Investing in These 2 Stocks Now Could Help You Retire Early","media":"Motley Fool","content":"<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RDFN","symbol_name":"Redfin Corp","start_time":0,"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","article_id":"2162724042","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","pubTimestamp":1630075046,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RDFN":"Redfin Corp","TDOC":"Teladoc Health Inc."},"translate_title":"现在投资这两种股票可以帮你提前退休","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDFN":0.9,"TDOC":0.9},"content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":813709519,"gmtCreate":1630241003931,"gmtModify":1676530249360,"author":{"id":"3562815822807212","authorId":"3562815822807212","name":"Favian","avatar":"https://static.tigerbbs.com/3c9db4d731960e756da0c07d6b32f34a","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1},"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813709519","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":813864381,"gmtCreate":1630186390143,"gmtModify":1676530238124,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f3e049e64de259e717c6e652c0aca653","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":4,"crmLevelSwitch":0},"htmlText":"tKs 4 tips.liken comment","listText":"tKs 4 tips.liken comment","text":"tKs 4 tips.liken comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/813864381","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5684887,"gmtCreate":1630241001061,"gmtModify":1663233071873,"authorId":3562815822807212,"author":{"id":3562815822807212,"authorId":3562815822807212,"name":"Favian","avatar":"https://static.tigerbbs.com/3c9db4d731960e756da0c07d6b32f34a","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.10","exceedPercentage":"93.02%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813864381,"type":1,"supId":0,"prevId":0,"content":"okie","text":"okie","html":"okie"},{"id":5679259,"gmtCreate":1630197934808,"gmtModify":1663233045925,"authorId":3579724486389386,"author":{"id":3579724486389386,"authorId":3579724486389386,"name":"DannyPhan","avatar":"https://static.tigerbbs.com/8241cecd85e391f36a47705d16eb854d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813864381,"type":1,"supId":0,"prevId":0,"content":"thanks","text":"thanks","html":"thanks"}],"langContent":"EN"},{"id":813017593,"gmtCreate":1630113833612,"gmtModify":1676530227377,"author":{"id":"3582032488737822","authorId":"3582032488737822","name":"sophialoh","avatar":"https://static.tigerbbs.com/7dac6447403db982c647955f9f44f00d","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"this is interesting","listText":"this is interesting","text":"this is interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/813017593","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5679159,"gmtCreate":1630197242032,"gmtModify":1663233045838,"authorId":3581571479581183,"author":{"id":3581571479581183,"authorId":3581571479581183,"name":"1Robo","avatar":"https://static.tigerbbs.com/d6d78c3153b562ef72e04f138b8a4f8a","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813017593,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":819457192,"gmtCreate":1630101192016,"gmtModify":1676530223067,"author":{"id":"3584052109735205","authorId":"3584052109735205","name":"Slowmopi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819457192","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819488231,"gmtCreate":1630088508123,"gmtModify":1676530222157,"author":{"id":"3571612770300673","authorId":"3571612770300673","name":"Rickyt089","avatar":"https://static.tigerbbs.com/4e75fb09fa53aa8d7db329d6599d40c1","vip":1,"crmLevel":5,"crmLevelSwitch":1},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819488231","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5678323,"gmtCreate":1630186404872,"gmtModify":1663233045628,"authorId":3576260758860416,"author":{"id":3576260758860416,"authorId":3576260758860416,"name":"andrew123","avatar":"https://community-static.tradeup.com/news/f3e049e64de259e717c6e652c0aca653","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819488231,"type":1,"supId":0,"prevId":0,"content":"done.like back","text":"done.like back","html":"done.like back"}],"langContent":"EN"},{"id":819592170,"gmtCreate":1630075807990,"gmtModify":1676530218949,"author":{"id":"3563444039721293","authorId":"3563444039721293","name":"Potatoclown","avatar":"https://static.tigerbbs.com/91f386b7c484ef56ecb6f1ca38fc4291","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"I want to retire now","listText":"I want to retire now","text":"I want to retire now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/819592170","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5686470,"gmtCreate":1630274139890,"gmtModify":1663233079638,"authorId":3585117333172534,"author":{"id":3585117333172534,"authorId":3585117333172534,"name":"lsn_9812","avatar":"https://static.tigerbbs.com/c7410d59f0fd140fa5ced8f35a7f9749","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819592170,"type":1,"supId":0,"prevId":0,"content":"????","text":"????","html":"????"},{"id":5671245,"gmtCreate":1630108631351,"gmtModify":1663233010131,"authorId":3575859659136593,"author":{"id":3575859659136593,"authorId":3575859659136593,"name":"MOON88","avatar":"https://static.tigerbbs.com/f09b0d1b368ce9762e9af5a440d99d98","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819592170,"type":1,"supId":0,"prevId":0,"content":"Cool","text":"Cool","html":"Cool"},{"id":5670000,"gmtCreate":1630088514739,"gmtModify":1663233004847,"authorId":3571612770300673,"author":{"id":3571612770300673,"authorId":3571612770300673,"name":"Rickyt089","avatar":"https://static.tigerbbs.com/4e75fb09fa53aa8d7db329d6599d40c1","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.06","exceedPercentage":"93.81%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819592170,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"},{"id":5669118,"gmtCreate":1630078329263,"gmtModify":1663233001441,"authorId":3563667976523421,"author":{"id":3563667976523421,"authorId":3563667976523421,"name":"ZStarWyvernZ","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.11","exceedPercentage":"93.95%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":3580686343307813,"repliedAuthor":{"id":3580686343307813,"authorId":3580686343307813,"name":"CarmenMok","avatar":"https://static.tigerbbs.com/b40679fa51d81e9ae96a79fd564b4859","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":819592170,"type":1,"supId":5668578,"prevId":5668637,"content":"<u>cool</u>","text":"<u>cool</u>","html":"<u>cool</u>"},{"id":5668578,"gmtCreate":1630075816679,"gmtModify":1663232999749,"authorId":3563444039721293,"author":{"id":3563444039721293,"authorId":3563444039721293,"name":"Potatoclown","avatar":"https://static.tigerbbs.com/91f386b7c484ef56ecb6f1ca38fc4291","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819592170,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"}],"langContent":"EN"},{"id":819596997,"gmtCreate":1630075740019,"gmtModify":1676530218834,"author":{"id":"3580344868125116","authorId":"3580344868125116","name":"gum","avatar":"https://static.tigerbbs.com/990e3e89d27ba7bcacf0155983f3fa87","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Any stocks that can help me to retire immediately?&nbsp;","listText":"Any stocks that can help me to retire immediately?&nbsp;","text":"Any stocks that can help me to retire immediately?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819596997","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819591273,"gmtCreate":1630075656892,"gmtModify":1676530218806,"author":{"id":"3585701253376375","authorId":"3585701253376375","name":"Glarethis","avatar":"https://static.tigerbbs.com/9ea7dfe17565fceb06ac23a420fcc4dd","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819591273","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819591190,"gmtCreate":1630075643410,"gmtModify":1676530218802,"author":{"id":"3581586064432892","authorId":"3581586064432892","name":"Skygeemusic","avatar":"https://static.tigerbbs.com/3f99d0ab8a8308e7405bd556cee37483","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"How reliable is this prediction?&nbsp;","listText":"How reliable is this prediction?&nbsp;","text":"How reliable is this prediction?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819591190","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819505985,"gmtCreate":1630075335547,"gmtModify":1676530218673,"author":{"id":"3568089111846836","authorId":"3568089111846836","name":"Ladious","avatar":"https://static.tigerbbs.com/8c7a0777ad403c9882135b0067a24d7e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819505985","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5668484,"gmtCreate":1630075400117,"gmtModify":1663232998938,"authorId":3583542338461065,"author":{"id":3583542338461065,"authorId":3583542338461065,"name":"Yulio","avatar":"https://static.tigerbbs.com/037e3a87ba0e28ca2573a2264ea74e47","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819505985,"type":1,"supId":0,"prevId":0,"content":"Liked","text":"Liked","html":"Liked"}],"langContent":"EN"},{"id":819502646,"gmtCreate":1630075313485,"gmtModify":1676530218666,"author":{"id":"3573986430688942","authorId":"3573986430688942","name":"themonkey","avatar":"https://static.tigerbbs.com/573a67d390101884216129f5c49fe8a0","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"[摳鼻]&nbsp;[摳鼻]&nbsp;[摳鼻]&nbsp;","listText":"[摳鼻]&nbsp;[摳鼻]&nbsp;[摳鼻]&nbsp;","text":"[摳鼻] [摳鼻] [摳鼻]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819502646","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5668506,"gmtCreate":1630075506141,"gmtModify":1663232998934,"authorId":3582771700317616,"author":{"id":3582771700317616,"authorId":3582771700317616,"name":"Xann","avatar":"https://static.tigerbbs.com/b936c65d357a7d2d686ad9e6335c3c18","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819502646,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"CN"},{"id":819508677,"gmtCreate":1630075168599,"gmtModify":1676530218649,"author":{"id":"4088919942402510","authorId":"4088919942402510","name":"CK88","avatar":"https://static.tigerbbs.com/bd256f54225ce528d810a369ab8365de","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/819508677","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5668446,"gmtCreate":1630075235242,"gmtModify":1663232999026,"authorId":3572496817285200,"author":{"id":3572496817285200,"authorId":3572496817285200,"name":"terry89","avatar":"https://static.tigerbbs.com/a8f3d3a49b2f88f3d66f162d57b571e1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819508677,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5668444,"gmtCreate":1630075229199,"gmtModify":1663232998235,"authorId":3581809688048652,"author":{"id":3581809688048652,"authorId":3581809688048652,"name":"lowniu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819508677,"type":1,"supId":0,"prevId":0,"content":"Yeah","text":"Yeah","html":"Yeah"}],"langContent":"EN"},{"id":819501602,"gmtCreate":1630075119106,"gmtModify":1676530218608,"author":{"id":"3578179845340728","authorId":"3578179845340728","name":"Finree","avatar":"https://static.tigerbbs.com/90e0afcf8b7bfce8ce34256846ba6981","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"High imagination stock&nbsp;[微笑]&nbsp;","listText":"High imagination stock&nbsp;[微笑]&nbsp;","text":"High imagination stock [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819501602","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":819501333,"gmtCreate":1630075106622,"gmtModify":1676530218584,"author":{"id":"3576527829922352","authorId":"3576527829922352","name":"Kelvinneo","avatar":"https://static.tigerbbs.com/02f9dc9fba8b950702638da01ab252b8","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/819501333","repostId":2162724042,"repostType":4,"repost":{"id":"2162724042","pubTimestamp":1630075046,"share":"https://www.laohu8.com/m/news/2162724042?lang=&edition=full","pubTime":"2021-08-27 22:37","market":"us","language":"en","title":"Investing in These 2 Stocks Now Could Help You Retire Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2162724042","media":"Motley Fool","summary":"Stocks in transformational companies can take investors a long way toward funding retirement.","content":"<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as <b>Amazon</b> and&nbsp;<b>Apple</b>, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.</p>\n<p>Nonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as <b>Redfin </b>(NASDAQ:RDFN) and <b>Teladoc Health </b>(NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F640462%2Fgettyimages-482134861.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Redfin</h2>\n<p>Redfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.</p>\n<p>The company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b>, whose agents still charge full-price commissions. It also competes well with <b>Opendoor Technologies,</b> whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.</p>\n<p>Redfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million&nbsp;in revenue so far in 2021, an 83%&nbsp;increase compared with the first two quarters of 2020.</p>\n<p>Redfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.</p>\n<p>Additionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define&nbsp;the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.</p>\n<h2>Teladoc Health</h2>\n<p>Teladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.</p>\n<p>At first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.</p>\n<p>Grand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.</p>\n<p>At the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.</p>\n<p>Teladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.</p>\n<p>Despite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing in These 2 Stocks Now Could Help You Retire Early</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting in These 2 Stocks Now Could Help You Retire Early\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","RDFN":"Redfin Corp"},"source_url":"https://www.fool.com/investing/2021/08/27/investing-in-these-2-stocks-now-could-help-you-ret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162724042","content_text":"Many new investors dream of buying stocks that will ultimately help them retire early. However, the success stories everybody knows, such as Amazon and Apple, now have market caps in the trillions, meaning they have grown too big to turn modest amounts into millions.\nNonetheless, many smaller companies leading emerging industries have not yet reached their full long-term growth potential. Consequently, emerging stocks such as Redfin (NASDAQ:RDFN) and Teladoc Health (NYSE:TDOC) could deliver the gains needed to help investors exit the workforce sooner. Are they for you?\nImage source: Getty Images.\nRedfin\nRedfin is a full-service real estate brokerage that uses marketing technology to reduce the costs of buying or selling a home -- giving it the opportunity to upend the cost structure of real estate transactions. Agent commissions alone can amount to 6% of the sales price -- 3% each for the buying agent and the seller's representative. However, Redfin performs its client's side of the transaction for 1%. On a $400,000 house, that would cut the commission from $24,000 to $16,000.\nThe company also offers services such as fixing up a house to sell. Still, even this concierge service amounts to only a 2% commission. This helps Redfin stand out from Zillow Group, whose agents still charge full-price commissions. It also competes well with Opendoor Technologies, whose strategy of buying homes in hopes of flipping them for a profit will only appeal to a subset of sellers.\nRedfin has not yet turned profitable, as a $5.1 million income tax benefit cut its losses for the second quarter to $64 million, down from $67 million in the same period in 2020. Still, Redfin's strategy has helped it produce $740 million in revenue so far in 2021, an 83% increase compared with the first two quarters of 2020.\nRedfin did not offer guidance beyond the third quarter, but it forecasts revenue growth between 124% and 128% compared with the third quarter of 2020. The absence of guidance beyond Q3 indicates a potential short-term slowdown related to COVID-19, but no evidence of such an event has emerged.\nAdditionally, because it has recently given back most of its net gains, Redfin stock trades at a price-to-sales (P/S) ratio of 4.4 at recent prices. This comes in slightly above Opendoor's sales multiple of 4.1 and below Zillow's P/S ratio of 6.4. Moreover, Redfin holds the lowest market cap at roughly $5 billion, compared to $10 billion for Opendoor and $25 billion for Zillow. Because it could come to define the entire residential real estate market with its lower price points, Redfin appears to hold the most potential of the three for stock price growth.\nTeladoc Health\nTeladoc has prospered by leading the way in the telehealth segment. While the company has existed since 2012, its value became apparent during the COVID-19 pandemic as it allowed users to see a doctor without leaving home. Teladoc has also built a significant international presence, delivering care in more than 125 countries.\nAt first glance, Teladoc may appear to have a narrow competitive moat, since, in theory, any doctor with video conferencing can provide this service. However, Teladoc offers a big advantage over your local provider with its 24/7 availability. Moreover, its latest major acquisition, Livongo Health, allows it to follow patients through their entire health journey, meaning it can monitor and test conditions such as blood pressure or glucose level on a periodic basis. This expanded view of a patient's health gives Teladoc a competitive advantage over other telehealth providers.\nGrand View Research valued the telehealth market valued at almost $56 billion in 2020, and it forecasts a 22% compound annual growth rate for the industry through 2028. The financials indicate that while Teladoc has lots of room to grow, it has captured a big chunk of this market already; during the first six months of 2021, Teladoc brought in $957 million, a 127% increase from the first two quarters of the previous year.\nAt the same time, the company's total expenses increased by 149%. Moreover, higher expenses for losses on extinguishment of debt, interest expenses, and income taxes led to a loss for the first half of 2021 of $333 million. Teladoc lost $55 million in the same period last year. Consequently, the company came in short of analysts' estimates in the second quarter.\nTeladoc's stock began losing value in February as interest rates began to rise. It continued to drop on fears that the launch of Amazon Care across the U.S. would undermine Teladoc's growth story. Also, a previous earnings miss in Q1 pushed the stock lower. Now, with the latest earnings shortfall, Teladoc sells for less than half its February high.\nDespite fears of a competitive threat from Amazon, the outlook calls for an 84% increase in revenue for 2021 compared with the previous year, and Teladoc's P/S ratio around 14 is its lowest sales multiple since just before the beginning of the pandemic. Moreover, at a market cap near $23 billion, Teladoc remains small enough that a modest investment could earn massive returns over time as the telehealth industry continues its expansion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5668432,"gmtCreate":1630075178342,"gmtModify":1663232998549,"authorId":4088919942402510,"author":{"id":4088919942402510,"authorId":4088919942402510,"name":"CK88","avatar":"https://static.tigerbbs.com/bd256f54225ce528d810a369ab8365de","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819501333,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5668430,"gmtCreate":1630075157162,"gmtModify":1663232998429,"authorId":4088390766152690,"author":{"id":4088390766152690,"authorId":4088390766152690,"name":"mingliang104","avatar":"https://static.tigerbbs.com/f1558c6d92782b6fb175674394d5c3ac","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819501333,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":90,"commentSize":14,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}